230 related articles for article (PubMed ID: 21317885)
1. UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53.
Wu H; Pomeroy SL; Ferreira M; Teider N; Mariani J; Nakayama KI; Hatakeyama S; Tron VA; Saltibus LF; Spyracopoulos L; Leng RP
Nat Med; 2011 Mar; 17(3):347-55. PubMed ID: 21317885
[TBL] [Abstract][Full Text] [Related]
2. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation.
Wu H; Leng RP
Cell Cycle; 2011 Jun; 10(12):1912-5. PubMed ID: 21558803
[TBL] [Abstract][Full Text] [Related]
3. Regulation of p53 level by UBE4B in breast cancer.
Zhang Y; Lv Y; Zhang Y; Gao H
PLoS One; 2014; 9(2):e90154. PubMed ID: 24587254
[TBL] [Abstract][Full Text] [Related]
4. UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation.
Du C; Wu H; Leng RP
Oncotarget; 2016 Jan; 7(3):2823-36. PubMed ID: 26673821
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1301 suppresses tumor cell migration and invasion by targeting the p53/UBE4B pathway in multiple human cancer cells.
Wang B; Wu H; Chai C; Lewis J; Pichiorri F; Eisenstat DD; Pomeroy SL; Leng RP
Cancer Lett; 2017 Aug; 401():20-32. PubMed ID: 28483517
[TBL] [Abstract][Full Text] [Related]
6. The SWIB/MDM2 motif of UBE4B activates the p53 pathway.
Wu HH; Leng S; Abuetabh Y; Sergi C; Eisenstat DD; Leng R
Mol Ther Nucleic Acids; 2023 Mar; 31():466-481. PubMed ID: 36865087
[TBL] [Abstract][Full Text] [Related]
7. UBE4B: a promising regulatory molecule in neuronal death and survival.
Zeinab RA; Wu H; Sergi C; Leng R
Int J Mol Sci; 2012 Dec; 13(12):16865-79. PubMed ID: 23222733
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma.
Zhang XF; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Wang DD; Jiang SS; Zheng HX; Lv L; Chen CL; Zhang HX; Xia JC
Mol Carcinog; 2016 Jan; 55(1):64-76. PubMed ID: 25557723
[TBL] [Abstract][Full Text] [Related]
10. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
Nie J; Xie P; Liu L; Xing G; Chang Z; Yin Y; Tian C; He F; Zhang L
J Biol Chem; 2010 Jul; 285(30):22818-30. PubMed ID: 20484049
[TBL] [Abstract][Full Text] [Related]
11. HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma.
Shi Y; Takenobu H; Kurata K; Yamaguchi Y; Yanagisawa R; Ohira M; Koike K; Nakagawara A; Jiang LL; Kamijo T
Eur J Cancer; 2010 Aug; 46(12):2324-34. PubMed ID: 20591651
[TBL] [Abstract][Full Text] [Related]
12. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes.
Banks D; Wu M; Higa LA; Gavrilova N; Quan J; Ye T; Kobayashi R; Sun H; Zhang H
Cell Cycle; 2006 Aug; 5(15):1719-29. PubMed ID: 16861890
[TBL] [Abstract][Full Text] [Related]
13. Mdm2 and MdmX partner to regulate p53.
Wang X; Jiang X
FEBS Lett; 2012 May; 586(10):1390-6. PubMed ID: 22673503
[TBL] [Abstract][Full Text] [Related]
14. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
Obata M; Kominami R; Mishima Y
Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
[TBL] [Abstract][Full Text] [Related]
15. MSL2 promotes Mdm2-independent cytoplasmic localization of p53.
Kruse JP; Gu W
J Biol Chem; 2009 Jan; 284(5):3250-3263. PubMed ID: 19033443
[TBL] [Abstract][Full Text] [Related]
16. p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction.
Medina-Medina I; Martínez-Sánchez M; Hernández-Monge J; Fahraeus R; Muller P; Olivares-Illana V
Protein Sci; 2018 May; 27(5):976-986. PubMed ID: 29524278
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract][Full Text] [Related]
18. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
[TBL] [Abstract][Full Text] [Related]
19. UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.
Zage PE; Sirisaengtaksin N; Liu Y; Gireud M; Brown BS; Palla S; Richards KN; Hughes DP; Bean AJ
Cancer; 2013 Feb; 119(4):915-23. PubMed ID: 22990745
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice.
Tian H; Tackmann NR; Jin A; Zheng J; Zhang Y
J Biol Chem; 2017 Dec; 292(52):21614-21622. PubMed ID: 29123033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]